Alexa Meitz, APRN

Alexa Meitz practices at West Central Gastroenterology in Saint Petersburg, Florida.

Alexa Meitz's NPI, 1255040788, was assigned on November 23, 2022. Alexa Meitz holds Florida license 11018090.

Alexa Meitz's primary practice is West Central Gastroenterology, at 1201 5th N Ave, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 347-0005.

Alexa Meitz's primary practice is West Central Gastroenterology in Saint Petersburg, Florida. Alexa Meitz is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Gastro Florida. Dmand AI also links Alexa Meitz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexa Meitz practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Alexa Meitz's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Alexa Meitz is licensed in Florida.

CMS data shows 149 Medicare services from Alexa Meitz across 4 procedure codes in 2024, all of them office visits, for 115 Medicare patients. Medicare paid $10,457 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Alexa Meitz in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Alexa Meitz's median patient age at 61, with 60% women.

In 2024, Alexa Meitz wrote 288 Medicare Part D claims for 149 patients. 78% of them were for generic drugs. CMS names the drug for 174 of them, across 5 drugs with 11 or more claims each, at $87,188 in total drug cost.

Alexa Meitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alexa Meitz as offering telehealth.

CMS Open Payments shows 144 general payments to Alexa Meitz from 24 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $820.